Morgan Stanley Maintains Underweight on Doximity, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Doximity (NYSE:DOCS) but raises the price target from $25 to $26.
August 09, 2024 | 11:22 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Doximity (NYSE:DOCS) but raises the price target from $25 to $26.
The Underweight rating suggests a bearish outlook, but the slight increase in the price target indicates some positive sentiment. Overall, the impact on the stock price is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100